Interestingly, Berard et al. (2012) have similarly described LCN2 label in spinal cord astrocytes in EAE; but not in postmortem brain tissue from patients with MS; which may be attributed to differences between humans and rodents, or to the stage of the disease. The gene discussed is LCN2; the disease is myeloid sarcoma.